AzTrials
AzTrials

Healthy LifestyleBETTERappNCT05837468

Better App: (Further-)Development and Evaluation of a Digital Lifestyle Programme

An observational study of Healthy Lifestyle and Health Behavior, run by Zuyd University of Applied Sciences.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In recent years, we developed and evaluated personalised lifestyle interventions, the BETTER programmes (BETER in Dutch, acronym for Move, Eat, Change). Underlying principle for all BETER programmes is that people with the same condition may have different underlying causes, so-called subtypes. Read more about this study

Who is it for?
Ages 16 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy Lifestyle, Health Behavior
What is being tested?
BETTERapp
How many people
65 participants
Where
No sites listed yet
Study dates
11 May 2023to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Persons aged 16 years or older who are overweight or obese (body mass index (BMI) of 25 or higher). N = 50 (sub-study 1); N= 15 (substudy 2)

Who may be able to join

  • Persons aged 16 years or older who are overweight or obese (body mass index (BMI) of 25 or higher)
  • Exclusion Criteria: : Insufficient mastery of Dutch language, insufficient basic smartphone skills.
  • -

Who cannot join

None listed.

About this study

Official title: Better App: (Further-)Development and Evaluation of a Digital Lifestyle Programme Based on Subtypes for Overweight or Obese People

In recent years, we developed and evaluated personalised lifestyle interventions, the BETTER programmes (BETER in Dutch, acronym for Move, Eat, Change). Underlying principle for all BETER programmes is that people with the same condition may have different underlying causes, so-called subtypes. In this follow-up project with a mixed methods design, we aim to evaluate and optimise the subtype-questionnaire/algorithm (study 1, interrater reliabiliy) and evaluate the digitised BETER programme, the BETTER App (study 2, case series design with qualitative and quantitative evaluation). The main questions it aims to answer are:

  1. What is the inter-rater reliability of two subtype experts and criterion validity of the symptom questionnaire compared with the experts for identifying overweight subtypes?
  2. How is the BETER app used and rated (process evaluation)? To answer question 1, participants complete a questionnaire and have two interviews with two experts. To answer question 2, participants use the BETTERapp for 6 weeks and complete a usability questionnaire after 3 and 6 weeks and participate in 1 or 2 focus group interviews. This study contributes to optimising the Minimal Viable Product of the BETER app to finally reach a mature version.
Read the detailed description

Backgroud: In the Netherlands, the number of people with chronic conditions has increased significantly in recent years and is expected to continue to grow (2). Treating chronic conditions is expensive and requires a lot of care and attention. This leads to high healthcare costs for both the patient and the government. The Dutch state spent 108 billion euros on medical and long-term care in 2021, the largest part of the 125 billion euros spent on Care and Welfare in total at that time (3). Chronic conditions have a major impact on people's quality of life. They can cause symptoms and limitations in daily life and also affect people's work participation.

Overweight and obesity are related to an increased risk of many chronic conditions, such as cardiovascular disease, type 2 diabetes and certain cancers. Lifestyle plays an important role in the development of overweight and obesity. It is known that an unhealthy diet and lack of physical activity are the most common causes of overweight and obesity. Therefore, it is important to take action and offer programmes to reverse these trends and promote healthy lifestyles (4,5). In contrast to a generalised approach, more personalised interventions match a person's specific needs, characteristics and situations and can therefore potentially lead to better results when it comes to sustainable changes in healthy lifestyles (6-8).

Personalised lifestyle interventions, the BETTER programmes, have been developed and evaluated by Zuyd University of Applied Sciences' lectorate of Nutrition, Lifestyle and Exercise in recent years. BETTER stands (BETER in Dutch) for Move, Eat, Change and the programmes focus on exercise, nutrition and behavioural change. Knowledge and insights from systems biological fundamental research provide the basis for these programmes to make lifestyle recommendations more personalised. There is increasing evidence, that people with the same condition, may have different underlying causes, which also makes lifestyle recommendations and interventions different (9). In the BETTER programmes, this knowledge is practically applied by working with subtypes.

The face-to-face BETTER lifestyle programme has been successfully applied to overweight and obese individuals. After completing the programme, participants lost weight, felt fitter and indicated they felt more in control of their lifestyle (10).

Within the BETTER programme, individual subtyping of participants took place by one or more experts. This is time-consuming and (relatively) expensive, especially for repeated measurements. In a pilot study, we investigated to what extent the subtype determined by means of a digital symptom questionnaire, including algorithm, corresponds to the subtype determined by an expert (criterion validity). First preliminary results showed that the outcomes from the questionnaire corresponded moderately to reasonably well with the expert classification. Based on these data, a machine learning algorithm was developed, capable of increasing the validity of the questionnaire (optimising weightings and dependencies of answers). This algorithm can be trained by adding new data (completed questionnaire and subtyping by expert). The algorithm works on the basis of the Semi-Supervised Classification principle (11).

Building on the results and conclusions from the above studies, the BETTER app is being developed in which the BETTER lifestyle programme for overweight people including the symptom questionnaire is offered in an automated and digitised way. Users can independently use personally relevant programme components in an accessible way, promoting self-management and self-regulation. The automated version of the symptom questionnaire plays an important role, since the programme content is, among other things, tailored to the user's underlying subtype. The automated questionnaire in the app therefore makes it easy to identify a change of subtype and adjust lifestyle advice accordingly. For the development of the content, the process to be followed and the design of the BETTER app, material from the previous BETTER programmes will be adapted. This development process takes place in co-creation with the target group in several iterations. This study contributes to optimising the Minimal Viable Product of the BETER app to eventually reach a mature version.

In this follow-up project, we aim to evaluate and optimise the subtype-questionnaire/algorithm (study 1, interrater reliability) and evaluate the digitised BETER programme, the BETTER App (study 2, case series design with qualitative and quantitative evaluation). The main questions it aims to answer are:

  1. What is the inter-rater reliability of two subtype experts and criterion validity of the symptom questionnaire compared with the experts for identifying overweight subtypes?
  2. How is the BETER app used and rated (process evaluation)?

Method Study design and measurements Sub-study 1: Symptom questionnaire To assess the inter-rater reliability and criterion validity of the subtype measurements, participants will be invited to a measurement session of up to 60 minutes. These measurement sessions will be offered on five different days and at different locations, and participants will be supervised by a researcher/research assistant. Participants go through three measurement sessions in separate rooms: (1) completion of the digital symptom questionnaire and demographic data (approx. 10 minutes), (2) interview with expert 1 (approx. 20 minutes), (3) interview with expert 2 (approx. 20 minutes).

Sub-study 2: Process evaluation BETER app This sub-study uses both quantitative and qualitative research methods in a case-series design. The baseline measurement (T0) takes place before the start of the app use, an intermediate measurement (T1) 3 weeks after the start and a final measurement at the conclusion of the app use (T2) 6 weeks after the start. At baseline, demographic data and expectations towards the app are collected. At T1 and T2, usage, experiences and ratings are mapped through a questionnaire (mHealth App Usability Questionnaire (MAUQ)) and focus group interviews. Log files automatically record how often a person logs in, which parts of the BETER app are used by participants and the duration of app use.

Study population Inclusion criteria: Persons aged 16 years or older who are overweight or obese (body mass index (BMI) of 25 or higher); exclusion criteria: Insufficient mastery of Dutch language, insufficient basic smartphone skills.

The BETTER app The BETTER app offers a 'tailor-made' lifestyle programme including the option of personal coaching for a duration of 6 weeks. The BETTER app is an automated and digitised lifestyle programme based on the previously developed and evaluated BETER programme. The BETER app was developed by researchers from the centre of expertise of Nutrition, Lifestyle and Exercise from Zuyd University of applied Sciences and the software developer HelloSunshine B.V. in co-creation with the target group. The app offers support for lifestyle behaviour change.

Data analysis To assess inter-rater reliability between the two experts, the Cohen's kappa (k) with standard error and percentage agreement is calculated between the two experts. A 95% confidence interval is used. Both the unweighted Kappa and the linearly weighted Kappa are calculated. By means of the weighted kappa, in case of difference, it can be examined whether this difference mainly occurs between certain subtypes and can be corrected for this (17).

For determining criterion validity, the degree of agreement is expressed as a correlation coefficient (r ≥ 0.8 is assessed as 'good' and used as a cut-off point). In addition, sensitivity, specificity and F1 score are assessed using a 5x5 table and the five "One versus Rest" ROC curves (18,19).

Process evaluation: all measured variables from quantitative measurements T0, T1 and T2 and logfiles are reported at group level for each measurement time point using descriptive statistics.

During the focus group interviews, data collection and data analysis take place partly simultaneously. We apply thematic coding and categorization already during the data collection process.

Data management and ethical considerations All data is stored on secure network drives and the anonymity of participants is guaranteed. Informed consent will be obtained prior to the measurements of substudy 1 and prior to completing T0 of substudy 2.

Being tested
BETTERapp
Keywords
Lifestyle, Behavior Change, Digital Lifestyle Application, Overweight, Subtypes
Medical subject headings
Health Behavior, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BETTERappBehavioural

    The BETTER app offers a 'tailor-made' lifestyle programme including the option of personal coaching for a duration of 6 weeks. The BETTER app is an automated and digitised lifestyle programme based on the previously developed and evaluated BETTER programme.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. inter-rater reliability

    To assess inter-rater reliability between the two experts, the Cohen's kappa (k) with standard error and percentage agreement is calculated between the two experts. A 95% confidence interval is used. Both the unweighted Kappa and the linearly weighted Kappa are calculated. By means of the weighted kappa, in case of difference, it can be examined whether this difference mainly occurs between certain subtypes and can be corrected for this

    Measured: from May to December 2023

  2. criterion validity

    For determining criterion validity, the degree of agreement is expressed as a correlation coefficient (r ≥ 0.8 is assessed as 'good' and used as a cut-off point). In addition, sensitivity, specificity and F1 score are assessed using a 5x5 table and the five "One versus Rest" ROC curves

    Measured: from May to December 2023

  3. Usability

    At T1 and T2, usage, experiences and ratings are mapped through a questionnaire (mHealth App Usability Questionnaire (MAUQ)) and focus group interviews

    Measured: from May to December 2023

  4. Use

    Log files automatically record how often a person logs in, which parts of the BETER app are used by participants and the duration of app use.

    Measured: from May to December 2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2023
  2. Study start11 May 2023 (estimated)
  3. Primary completion31 Oct 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
65 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05837468
Sponsor's protocol ID
METCZ20230037
Acronym
BETTERapp
Status last verified
Apr 2023
First submitted
18 Apr 2023
Last updated
1 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hassan Y, Head V, Jacob D, Bachmann MO, Diu S, Ford J. Lifestyle interventions for weight loss in adults with severe obesity: a systematic review. Clin Obes. 2016 Dec;6(6):395-403. doi: 10.1111/cob.12161. Epub 2016 Oct 27.

    PubMed 27788558
  • Burgess E, Hassmen P, Pumpa KL. Determinants of adherence to lifestyle intervention in adults with obesity: a systematic review. Clin Obes. 2017 Jun;7(3):123-135. doi: 10.1111/cob.12183. Epub 2017 Mar 15.

    PubMed 28296261
  • Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007 Feb 10;334(7588):299. doi: 10.1136/bmj.39063.689375.55. Epub 2007 Jan 19.

    PubMed 17237299
  • van der Valk ES, van den Akker ELT, Savas M, Kleinendorst L, Visser JA, Van Haelst MM, Sharma AM, van Rossum EFC. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev. 2019 Jun;20(6):795-804. doi: 10.1111/obr.12836. Epub 2019 Mar 1.

    PubMed 30821060
  • Trouwborst I, Gijbels A, Jardon KM, Siebelink E, Hul GB, Wanders L, Erdos B, Peter S, Singh-Povel CM, de Vogel-van den Bosch J, Adriaens ME, Arts ICW, Thijssen DHJ, Feskens EJM, Goossens GH, Afman LA, Blaak EE. Cardiometabolic health improvements upon dietary intervention are driven by tissue-specific insulin resistance phenotype: A precision nutrition trial. Cell Metab. 2023 Jan 3;35(1):71-83.e5. doi: 10.1016/j.cmet.2022.12.002.

    PubMed 36599304

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Lifestyle and Health Behavior, run by Zuyd University of Applied Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

inter-rater reliability (time frame: from May to December 2023). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05837468, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in